Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).
Journal: Drugs - real world outcomes
Published: December 11, 2025
Interstitial pneumonia with autoimmune features: A literature review.
Journal: Respiratory medicine
Published: September 02, 2025
Initial Evaluation of Pulmonary Hypertension Functional Classification Self-Report Measurement Properties: A Patient-Focused Measure.
Journal: Chest
Published: June 03, 2025
Corrigendum to ''Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)'' [J Heart Lung Transplant 43 (2024) 272-283].
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: May 15, 2025
Pericardial Effusion and Prostacyclin Analog Toxicity After Initiation of Sotatercept.
Journal: Pulmonary circulation
Published: April 03, 2025
Advancing MSC therapy: The next generation of potent mesenchymal stromal cells for systemic autoimmune rheumatic diseases.
Journal: Best practice & research. Clinical haematology
Published: April 01, 2025
A novel trained mesenchymal stromal cell-based therapy, HXB-319, effectively controls progressive glomerulonephritis in a murine lupus model.
Journal: Stem cells (Dayton, Ohio)
Published: March 21, 2025
Patient Perspectives and Clinical Insights Into the Diagnostic Journey From Connective Tissue Disease to Pulmonary Arterial Hypertension.
Journal: The Journal of rheumatology
Published: February 15, 2025
Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.
Journal: Journal of racial and ethnic health disparities
Published: February 09, 2025
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease.
Journal: Arthritis research & therapy
Published: October 07, 2024
Last Updated: 09/26/2026